ES2449496T3 - Dispositivo mejorado de implante para glaucoma - Google Patents
Dispositivo mejorado de implante para glaucoma Download PDFInfo
- Publication number
- ES2449496T3 ES2449496T3 ES04813050.4T ES04813050T ES2449496T3 ES 2449496 T3 ES2449496 T3 ES 2449496T3 ES 04813050 T ES04813050 T ES 04813050T ES 2449496 T3 ES2449496 T3 ES 2449496T3
- Authority
- ES
- Spain
- Prior art keywords
- aqueous humor
- drainage device
- passage structure
- eye
- elongated passage
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 239000007943 implant Substances 0.000 title description 29
- 208000010412 Glaucoma Diseases 0.000 title description 20
- 210000001742 aqueous humor Anatomy 0.000 claims abstract description 85
- 239000000463 material Substances 0.000 claims abstract description 57
- 210000002159 anterior chamber Anatomy 0.000 claims abstract description 34
- 239000012530 fluid Substances 0.000 claims abstract description 28
- 229920002367 Polyisobutene Polymers 0.000 claims abstract description 9
- 210000004027 cell Anatomy 0.000 claims abstract description 9
- 238000005538 encapsulation Methods 0.000 claims abstract description 8
- 230000000694 effects Effects 0.000 claims abstract description 5
- 231100000331 toxic Toxicity 0.000 claims abstract description 4
- 230000002588 toxic effect Effects 0.000 claims abstract description 4
- 210000001124 body fluid Anatomy 0.000 claims abstract description 3
- 239000010839 body fluid Substances 0.000 claims abstract description 3
- 210000003786 sclera Anatomy 0.000 claims description 36
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 13
- PPBRXRYQALVLMV-UHFFFAOYSA-N Styrene Chemical compound C=CC1=CC=CC=C1 PPBRXRYQALVLMV-UHFFFAOYSA-N 0.000 claims description 12
- 239000004793 Polystyrene Substances 0.000 claims description 6
- 235000011187 glycerol Nutrition 0.000 claims description 6
- 229920002223 polystyrene Polymers 0.000 claims description 6
- 229920001169 thermoplastic Polymers 0.000 claims description 6
- 239000004416 thermosoftening plastic Substances 0.000 claims description 6
- 230000014759 maintenance of location Effects 0.000 claims description 5
- 229920001400 block copolymer Polymers 0.000 claims description 4
- 229920001296 polysiloxane Polymers 0.000 claims description 4
- 229920005995 polystyrene-polyisobutylene Polymers 0.000 claims description 4
- CERQOIWHTDAKMF-UHFFFAOYSA-M Methacrylate Chemical compound CC(=C)C([O-])=O CERQOIWHTDAKMF-UHFFFAOYSA-M 0.000 claims description 3
- 125000003118 aryl group Chemical group 0.000 claims description 3
- 239000003795 chemical substances by application Substances 0.000 claims description 3
- 229920000642 polymer Polymers 0.000 claims description 3
- 229920002554 vinyl polymer Polymers 0.000 claims description 3
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical group CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 claims description 2
- OELQSSWXRGADDE-UHFFFAOYSA-N 2-methylprop-2-eneperoxoic acid Chemical compound CC(=C)C(=O)OO OELQSSWXRGADDE-UHFFFAOYSA-N 0.000 claims description 2
- VVQNEPGJFQJSBK-UHFFFAOYSA-N Methyl methacrylate Chemical compound COC(=O)C(C)=C VVQNEPGJFQJSBK-UHFFFAOYSA-N 0.000 claims description 2
- 239000000853 adhesive Substances 0.000 claims description 2
- 230000001070 adhesive effect Effects 0.000 claims description 2
- XYLMUPLGERFSHI-UHFFFAOYSA-N alpha-Methylstyrene Chemical compound CC(=C)C1=CC=CC=C1 XYLMUPLGERFSHI-UHFFFAOYSA-N 0.000 claims description 2
- SUPCQIBBMFXVTL-UHFFFAOYSA-N ethyl 2-methylprop-2-enoate Chemical compound CCOC(=O)C(C)=C SUPCQIBBMFXVTL-UHFFFAOYSA-N 0.000 claims description 2
- 239000003292 glue Substances 0.000 claims description 2
- 230000035876 healing Effects 0.000 claims description 2
- 229920002674 hyaluronan Polymers 0.000 claims description 2
- 229960003160 hyaluronic acid Drugs 0.000 claims description 2
- WTJKGGKOPKCXLL-RRHRGVEJSA-N phosphatidylcholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCCC=CCCCCCCCC WTJKGGKOPKCXLL-RRHRGVEJSA-N 0.000 claims description 2
- 229920000260 silastic Polymers 0.000 claims description 2
- 210000001508 eye Anatomy 0.000 description 64
- 210000000795 conjunctiva Anatomy 0.000 description 18
- 210000001519 tissue Anatomy 0.000 description 15
- 238000000034 method Methods 0.000 description 11
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 9
- 210000003205 muscle Anatomy 0.000 description 8
- 238000001356 surgical procedure Methods 0.000 description 7
- 239000003814 drug Substances 0.000 description 6
- 229940079593 drug Drugs 0.000 description 6
- 235000019589 hardness Nutrition 0.000 description 6
- 238000003780 insertion Methods 0.000 description 6
- 230000037431 insertion Effects 0.000 description 6
- 238000004519 manufacturing process Methods 0.000 description 6
- 210000001328 optic nerve Anatomy 0.000 description 6
- 239000004205 dimethyl polysiloxane Substances 0.000 description 5
- 235000013870 dimethyl polysiloxane Nutrition 0.000 description 5
- 239000000835 fiber Substances 0.000 description 5
- 238000002483 medication Methods 0.000 description 5
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 description 5
- 241001465754 Metazoa Species 0.000 description 4
- 206010029113 Neovascularisation Diseases 0.000 description 4
- 210000005252 bulbus oculi Anatomy 0.000 description 4
- 210000002808 connective tissue Anatomy 0.000 description 4
- 210000004087 cornea Anatomy 0.000 description 4
- 230000004410 intraocular pressure Effects 0.000 description 4
- CXQXSVUQTKDNFP-UHFFFAOYSA-N octamethyltrisiloxane Chemical compound C[Si](C)(C)O[Si](C)(C)O[Si](C)(C)C CXQXSVUQTKDNFP-UHFFFAOYSA-N 0.000 description 4
- 230000037361 pathway Effects 0.000 description 4
- 238000004987 plasma desorption mass spectroscopy Methods 0.000 description 4
- 210000005077 saccule Anatomy 0.000 description 4
- 201000002862 Angle-Closure Glaucoma Diseases 0.000 description 3
- 102000008186 Collagen Human genes 0.000 description 3
- 108010035532 Collagen Proteins 0.000 description 3
- 206010030348 Open-Angle Glaucoma Diseases 0.000 description 3
- 239000000560 biocompatible material Substances 0.000 description 3
- 210000004240 ciliary body Anatomy 0.000 description 3
- 229920001436 collagen Polymers 0.000 description 3
- 229920001577 copolymer Polymers 0.000 description 3
- 239000010410 layer Substances 0.000 description 3
- 230000007246 mechanism Effects 0.000 description 3
- 229920000098 polyolefin Polymers 0.000 description 3
- 239000002904 solvent Substances 0.000 description 3
- 210000001760 tenon capsule Anatomy 0.000 description 3
- 201000004569 Blindness Diseases 0.000 description 2
- 241000282412 Homo Species 0.000 description 2
- 206010020772 Hypertension Diseases 0.000 description 2
- 206010061876 Obstruction Diseases 0.000 description 2
- 241000405070 Percophidae Species 0.000 description 2
- 230000002159 abnormal effect Effects 0.000 description 2
- 230000002457 bidirectional effect Effects 0.000 description 2
- 239000002775 capsule Substances 0.000 description 2
- 230000007423 decrease Effects 0.000 description 2
- 238000001125 extrusion Methods 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 239000004033 plastic Substances 0.000 description 2
- 229920003023 plastic Polymers 0.000 description 2
- 238000006116 polymerization reaction Methods 0.000 description 2
- -1 polypropylene Polymers 0.000 description 2
- 201000006366 primary open angle glaucoma Diseases 0.000 description 2
- 229920002379 silicone rubber Polymers 0.000 description 2
- 208000032467 Aplastic anaemia Diseases 0.000 description 1
- 229920002799 BoPET Polymers 0.000 description 1
- 206010007559 Cardiac failure congestive Diseases 0.000 description 1
- 208000036828 Device occlusion Diseases 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 206010015548 Euthanasia Diseases 0.000 description 1
- 206010016654 Fibrosis Diseases 0.000 description 1
- 241000223783 Glaucoma Species 0.000 description 1
- 206010019280 Heart failures Diseases 0.000 description 1
- 206010021118 Hypotonia Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- VQTUBCCKSQIDNK-UHFFFAOYSA-N Isobutene Chemical group CC(C)=C VQTUBCCKSQIDNK-UHFFFAOYSA-N 0.000 description 1
- 208000000913 Kidney Calculi Diseases 0.000 description 1
- 108010044349 Maxitrol Proteins 0.000 description 1
- 208000007379 Muscle Hypotonia Diseases 0.000 description 1
- 206010029148 Nephrolithiasis Diseases 0.000 description 1
- 241000283977 Oryctolagus Species 0.000 description 1
- 239000004743 Polypropylene Substances 0.000 description 1
- 206010038687 Respiratory distress Diseases 0.000 description 1
- 201000001880 Sexual dysfunction Diseases 0.000 description 1
- 239000004809 Teflon Substances 0.000 description 1
- 229920006362 Teflon® Polymers 0.000 description 1
- 208000031737 Tissue Adhesions Diseases 0.000 description 1
- 230000005856 abnormality Effects 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 230000006978 adaptation Effects 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 210000003050 axon Anatomy 0.000 description 1
- 238000006065 biodegradation reaction Methods 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 238000000071 blow moulding Methods 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 238000003490 calendering Methods 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 210000003161 choroid Anatomy 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 230000006835 compression Effects 0.000 description 1
- 238000007906 compression Methods 0.000 description 1
- 238000000748 compression moulding Methods 0.000 description 1
- 230000008878 coupling Effects 0.000 description 1
- 238000010168 coupling process Methods 0.000 description 1
- 238000005859 coupling reaction Methods 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- UREBDLICKHMUKA-CXSFZGCWSA-N dexamethasone Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(F)[C@@H]1[C@@H]1C[C@@H](C)[C@@](C(=O)CO)(O)[C@@]1(C)C[C@@H]2O UREBDLICKHMUKA-CXSFZGCWSA-N 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 239000013536 elastomeric material Substances 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 230000004761 fibrosis Effects 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 238000007654 immersion Methods 0.000 description 1
- 238000002513 implantation Methods 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000002757 inflammatory effect Effects 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 238000001746 injection moulding Methods 0.000 description 1
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- 230000002045 lasting effect Effects 0.000 description 1
- 235000013490 limbo Nutrition 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 229940029062 maxitrol Drugs 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 238000013508 migration Methods 0.000 description 1
- 230000005012 migration Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000000465 moulding Methods 0.000 description 1
- 210000001087 myotubule Anatomy 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 210000004279 orbit Anatomy 0.000 description 1
- 238000005192 partition Methods 0.000 description 1
- 229920000728 polyester Polymers 0.000 description 1
- 239000004848 polyfunctional curative Substances 0.000 description 1
- 229920001155 polypropylene Polymers 0.000 description 1
- 229920001343 polytetrafluoroethylene Polymers 0.000 description 1
- 239000004810 polytetrafluoroethylene Substances 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 210000001747 pupil Anatomy 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 210000001525 retina Anatomy 0.000 description 1
- 238000004626 scanning electron microscopy Methods 0.000 description 1
- 230000037390 scarring Effects 0.000 description 1
- 231100000872 sexual dysfunction Toxicity 0.000 description 1
- 238000007493 shaping process Methods 0.000 description 1
- 239000004945 silicone rubber Substances 0.000 description 1
- 239000002356 single layer Substances 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 238000000807 solvent casting Methods 0.000 description 1
- 238000009987 spinning Methods 0.000 description 1
- 238000005507 spraying Methods 0.000 description 1
- 229910001220 stainless steel Inorganic materials 0.000 description 1
- 239000010935 stainless steel Substances 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 229940100615 topical ointment Drugs 0.000 description 1
- 229920000428 triblock copolymer Polymers 0.000 description 1
- 238000007666 vacuum forming Methods 0.000 description 1
- 230000002792 vascular Effects 0.000 description 1
- 230000000007 visual effect Effects 0.000 description 1
- 230000004393 visual impairment Effects 0.000 description 1
- 210000004127 vitreous body Anatomy 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
- 230000003442 weekly effect Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F9/00—Methods or devices for treatment of the eyes; Devices for putting in contact-lenses; Devices to correct squinting; Apparatus to guide the blind; Protective devices for the eyes, carried on the body or in the hand
- A61F9/007—Methods or devices for eye surgery
- A61F9/00781—Apparatus for modifying intraocular pressure, e.g. for glaucoma treatment
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2210/00—Particular material properties of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2210/0071—Particular material properties of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof thermoplastic
Landscapes
- Health & Medical Sciences (AREA)
- Ophthalmology & Optometry (AREA)
- Heart & Thoracic Surgery (AREA)
- Surgery (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Vascular Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Prostheses (AREA)
- Materials For Medical Uses (AREA)
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US52696303P | 2003-12-05 | 2003-12-05 | |
| US526963P | 2003-12-05 | ||
| US56529104P | 2004-04-26 | 2004-04-26 | |
| US565291P | 2004-04-26 | ||
| PCT/US2004/040661 WO2005055873A2 (en) | 2003-12-05 | 2004-12-03 | Improved glaucoma implant device |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ES2449496T3 true ES2449496T3 (es) | 2014-03-20 |
Family
ID=34681519
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES04813050.4T Expired - Lifetime ES2449496T3 (es) | 2003-12-05 | 2004-12-03 | Dispositivo mejorado de implante para glaucoma |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US7431709B2 (enExample) |
| EP (1) | EP1689333B1 (enExample) |
| JP (1) | JP5090742B2 (enExample) |
| AU (2) | AU2004296205B2 (enExample) |
| CA (1) | CA2549155C (enExample) |
| ES (1) | ES2449496T3 (enExample) |
| WO (1) | WO2005055873A2 (enExample) |
Families Citing this family (135)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20020188037A1 (en) * | 1999-04-15 | 2002-12-12 | Chudzik Stephen J. | Method and system for providing bioactive agent release coating |
| RU2234894C2 (ru) | 1999-04-26 | 2004-08-27 | Джи-Эм-Пи Вижн Солюшнз, Инк. | Расширительное устройство и способ лечения глаукомы |
| US20050119737A1 (en) * | 2000-01-12 | 2005-06-02 | Bene Eric A. | Ocular implant and methods for making and using same |
| US7867186B2 (en) | 2002-04-08 | 2011-01-11 | Glaukos Corporation | Devices and methods for treatment of ocular disorders |
| US6638239B1 (en) | 2000-04-14 | 2003-10-28 | Glaukos Corporation | Apparatus and method for treating glaucoma |
| US7431710B2 (en) | 2002-04-08 | 2008-10-07 | Glaukos Corporation | Ocular implants with anchors and methods thereof |
| CA2442652C (en) | 2001-04-07 | 2011-01-04 | Glaukos Corporation | Glaucoma stent and methods thereof for glaucoma treatment |
| US7331984B2 (en) | 2001-08-28 | 2008-02-19 | Glaukos Corporation | Glaucoma stent for treating glaucoma and methods of use |
| US20030229303A1 (en) * | 2002-03-22 | 2003-12-11 | Haffner David S. | Expandable glaucoma implant and methods of use |
| US20040225250A1 (en) | 2003-05-05 | 2004-11-11 | Michael Yablonski | Internal shunt and method for treating glaucoma |
| US7291125B2 (en) | 2003-11-14 | 2007-11-06 | Transcend Medical, Inc. | Ocular pressure regulation |
| US20060036207A1 (en) * | 2004-02-24 | 2006-02-16 | Koonmen James P | System and method for treating glaucoma |
| US7364564B2 (en) * | 2004-03-02 | 2008-04-29 | Becton, Dickinson And Company | Implant having MEMS flow module with movable, flow-controlling baffle |
| US7384550B2 (en) * | 2004-02-24 | 2008-06-10 | Becton, Dickinson And Company | Glaucoma implant having MEMS filter module |
| US7544176B2 (en) * | 2005-06-21 | 2009-06-09 | Becton, Dickinson And Company | Glaucoma implant having MEMS flow module with flexing diaphragm for pressure regulation |
| US20060219627A1 (en) * | 2005-03-31 | 2006-10-05 | Rodgers M S | MEMS filter module with concentric filtering walls |
| US20060173399A1 (en) * | 2005-02-01 | 2006-08-03 | Rodgers M S | MEMS flow module with pivoting-type baffle |
| US20060206049A1 (en) * | 2005-03-14 | 2006-09-14 | Rodgers M S | MEMS flow module with piston-type pressure regulating structure |
| US7226540B2 (en) * | 2004-02-24 | 2007-06-05 | Becton, Dickinson And Company | MEMS filter module |
| US20090043365A1 (en) * | 2005-07-18 | 2009-02-12 | Kolis Scientific, Inc. | Methods, apparatuses, and systems for reducing intraocular pressure as a means of preventing or treating open-angle glaucoma |
| CA2927921C (en) | 2006-01-17 | 2019-06-04 | Transcend Medical, Inc. | Glaucoma treatment device |
| EP3338743A1 (en) | 2006-01-17 | 2018-06-27 | Novartis Ag | Drug delivery treatment device |
| US20070293807A1 (en) * | 2006-05-01 | 2007-12-20 | Lynch Mary G | Dual drainage pathway shunt device and method for treating glaucoma |
| US7909789B2 (en) | 2006-06-26 | 2011-03-22 | Sight Sciences, Inc. | Intraocular implants and methods and kits therefor |
| US9095411B2 (en) | 2010-11-15 | 2015-08-04 | Aquesys, Inc. | Devices for deploying intraocular shunts |
| US20080108933A1 (en) * | 2006-06-30 | 2008-05-08 | Dao-Yi Yu | Methods, Systems and Apparatus for Relieving Pressure in an Organ |
| US8801766B2 (en) | 2010-11-15 | 2014-08-12 | Aquesys, Inc. | Devices for deploying intraocular shunts |
| US8308701B2 (en) | 2010-11-15 | 2012-11-13 | Aquesys, Inc. | Methods for deploying intraocular shunts |
| US8852137B2 (en) | 2010-11-15 | 2014-10-07 | Aquesys, Inc. | Methods for implanting a soft gel shunt in the suprachoroidal space |
| US8852256B2 (en) | 2010-11-15 | 2014-10-07 | Aquesys, Inc. | Methods for intraocular shunt placement |
| US20120123316A1 (en) | 2010-11-15 | 2012-05-17 | Aquesys, Inc. | Intraocular shunts for placement in the intra-tenon's space |
| US8828070B2 (en) | 2010-11-15 | 2014-09-09 | Aquesys, Inc. | Devices for deploying intraocular shunts |
| US10085884B2 (en) | 2006-06-30 | 2018-10-02 | Aquesys, Inc. | Intraocular devices |
| US8974511B2 (en) | 2010-11-15 | 2015-03-10 | Aquesys, Inc. | Methods for treating closed angle glaucoma |
| US8663303B2 (en) | 2010-11-15 | 2014-03-04 | Aquesys, Inc. | Methods for deploying an intraocular shunt from a deployment device and into an eye |
| US8721702B2 (en) | 2010-11-15 | 2014-05-13 | Aquesys, Inc. | Intraocular shunt deployment devices |
| US8758290B2 (en) | 2010-11-15 | 2014-06-24 | Aquesys, Inc. | Devices and methods for implanting a shunt in the suprachoroidal space |
| WO2008013913A2 (en) * | 2006-07-26 | 2008-01-31 | Aciont, Inc. | Method and device for minimally invasive site specific ocular drug delivery |
| US20080097335A1 (en) * | 2006-08-04 | 2008-04-24 | Allergan, Inc. | Ocular implant delivery assemblies |
| EP2059282A4 (en) * | 2006-09-06 | 2014-04-09 | Innfocus Inc | APPARATUS, METHODS AND DEVICES FOR THE TREATMENT OF OCULAR DISORDERS |
| AU2007319383A1 (en) | 2006-11-10 | 2008-05-22 | Glaukos Corporation | Uveoscleral shunt and methods for implanting same |
| DE102007004906A1 (de) * | 2007-01-25 | 2008-07-31 | Universität Rostock | Augenimplantat |
| US7887830B2 (en) * | 2007-02-27 | 2011-02-15 | Boston Scientific Scimed, Inc. | Medical devices having polymeric regions based on styrene-isobutylene copolymers |
| WO2009012406A1 (en) | 2007-07-17 | 2009-01-22 | Transcend Medical, Inc. | Ocular implant with hydrogel expansion capabilities reference to priority document |
| US8968396B2 (en) | 2007-07-23 | 2015-03-03 | Powervision, Inc. | Intraocular lens delivery systems and methods of use |
| US20090082862A1 (en) | 2007-09-24 | 2009-03-26 | Schieber Andrew T | Ocular Implant Architectures |
| US20170360609A9 (en) | 2007-09-24 | 2017-12-21 | Ivantis, Inc. | Methods and devices for increasing aqueous humor outflow |
| US7740604B2 (en) | 2007-09-24 | 2010-06-22 | Ivantis, Inc. | Ocular implants for placement in schlemm's canal |
| US8734377B2 (en) | 2007-09-24 | 2014-05-27 | Ivantis, Inc. | Ocular implants with asymmetric flexibility |
| US8808222B2 (en) | 2007-11-20 | 2014-08-19 | Ivantis, Inc. | Methods and apparatus for delivering ocular implants into the eye |
| US8512404B2 (en) | 2007-11-20 | 2013-08-20 | Ivantis, Inc. | Ocular implant delivery system and method |
| JP2011513002A (ja) | 2008-03-05 | 2011-04-28 | イバンティス インコーポレイテッド | 緑内障を治療する方法及び器具 |
| ES2640867T3 (es) * | 2008-06-25 | 2017-11-07 | Novartis Ag | Implante ocular con capacidad de cambio de forma |
| US8353856B2 (en) | 2008-11-05 | 2013-01-15 | Abbott Medical Optics Inc. | Glaucoma drainage shunts and methods of use |
| CA2972136C (en) * | 2008-12-05 | 2019-08-06 | Ivantis, Inc. | Cannula for ocular implant delivery system |
| ES2920877T3 (es) | 2009-01-28 | 2022-08-11 | Alcon Inc | Sistema de colocación de implantes oculares |
| US9636255B2 (en) * | 2009-02-13 | 2017-05-02 | Dose Medical Corporation | Uveoscleral drug delivery implant and methods for implanting the same |
| EP2410959B1 (en) * | 2009-03-26 | 2014-06-11 | Abbott Medical Optics Inc. | Glaucoma shunts with flow management and improved surgical performance |
| WO2012071476A2 (en) | 2010-11-24 | 2012-05-31 | David Haffner | Drug eluting ocular implant |
| EP2451503B1 (en) | 2009-07-09 | 2018-10-24 | Ivantis, Inc. | Ocular implants and methods for delivering ocular implants into the eye |
| CA2766131C (en) | 2009-07-09 | 2017-10-24 | Ivantis, Inc. | Single operator device for delivering an ocular implant |
| US20110098809A1 (en) | 2009-10-23 | 2011-04-28 | John Wardle | Ocular Implant System and Method |
| WO2011075481A1 (en) * | 2009-12-16 | 2011-06-23 | Allergan, Inc. | Intracameral devices for sustained delivery |
| US8529492B2 (en) | 2009-12-23 | 2013-09-10 | Trascend Medical, Inc. | Drug delivery devices and methods |
| JP5856569B2 (ja) | 2010-02-05 | 2016-02-10 | サイト サイエンシーズ， インコーポレイテッド | 眼内圧を低減するためのデバイスと、それを含むキット |
| WO2011106435A2 (en) | 2010-02-23 | 2011-09-01 | Powervision, Inc. | Fluid for accommodating intraocular lenses |
| WO2011163505A1 (en) | 2010-06-23 | 2011-12-29 | Ivantis, Inc. | Ocular implants deployed in schlemm's canal of the eye |
| US8585629B2 (en) | 2010-11-15 | 2013-11-19 | Aquesys, Inc. | Systems for deploying intraocular shunts |
| US10842671B2 (en) | 2010-11-15 | 2020-11-24 | Aquesys, Inc. | Intraocular shunt placement in the suprachoroidal space |
| EP2517619B1 (en) | 2011-04-27 | 2013-05-22 | Istar Medical | Improvements in or relating to glaucoma management and treatment |
| US8657776B2 (en) | 2011-06-14 | 2014-02-25 | Ivantis, Inc. | Ocular implants for delivery into the eye |
| US8765210B2 (en) | 2011-12-08 | 2014-07-01 | Aquesys, Inc. | Systems and methods for making gelatin shunts |
| US8852136B2 (en) | 2011-12-08 | 2014-10-07 | Aquesys, Inc. | Methods for placing a shunt into the intra-scleral space |
| US9610195B2 (en) | 2013-02-27 | 2017-04-04 | Aquesys, Inc. | Intraocular shunt implantation methods and devices |
| US10080682B2 (en) | 2011-12-08 | 2018-09-25 | Aquesys, Inc. | Intrascleral shunt placement |
| US9808373B2 (en) | 2013-06-28 | 2017-11-07 | Aquesys, Inc. | Intraocular shunt implantation |
| US8663150B2 (en) | 2011-12-19 | 2014-03-04 | Ivantis, Inc. | Delivering ocular implants into the eye |
| US9101444B2 (en) * | 2012-01-12 | 2015-08-11 | Innfocus, Inc. | Method, surgical kit and device for treating glaucoma |
| US9241831B2 (en) | 2012-02-13 | 2016-01-26 | Iridex Corporation | Reduction of intraocular pressure in the eye using a tubular clip |
| ES2961369T3 (es) | 2012-03-20 | 2024-03-11 | Sight Sciences Inc | Sistemas de entrega ocular |
| WO2013148275A2 (en) | 2012-03-26 | 2013-10-03 | Glaukos Corporation | System and method for delivering multiple ocular implants |
| US9358156B2 (en) | 2012-04-18 | 2016-06-07 | Invantis, Inc. | Ocular implants for delivery into an anterior chamber of the eye |
| US10085633B2 (en) | 2012-04-19 | 2018-10-02 | Novartis Ag | Direct visualization system for glaucoma treatment |
| US9241832B2 (en) | 2012-04-24 | 2016-01-26 | Transcend Medical, Inc. | Delivery system for ocular implant |
| US8858491B2 (en) * | 2012-05-23 | 2014-10-14 | Alcon Research, Ltd. | Pre-biased membrane valve |
| EP3228286A1 (en) | 2012-09-17 | 2017-10-11 | Novartis AG | Expanding ocular impant devices |
| ITFI20120226A1 (it) * | 2012-10-25 | 2014-04-26 | Era Endoscopy S R L | Guida tubolare flessibile ed estensibile e suo procedimento produttivo |
| WO2014078288A1 (en) | 2012-11-14 | 2014-05-22 | Transcend Medical, Inc. | Flow promoting ocular implant |
| WO2014085450A1 (en) | 2012-11-28 | 2014-06-05 | Ivantis, Inc. | Apparatus for delivering ocular implants into an anterior chamber of the eye |
| US9125723B2 (en) | 2013-02-19 | 2015-09-08 | Aquesys, Inc. | Adjustable glaucoma implant |
| US10159600B2 (en) | 2013-02-19 | 2018-12-25 | Aquesys, Inc. | Adjustable intraocular flow regulation |
| US10517759B2 (en) | 2013-03-15 | 2019-12-31 | Glaukos Corporation | Glaucoma stent and methods thereof for glaucoma treatment |
| WO2014145562A1 (en) | 2013-03-15 | 2014-09-18 | Powervision, Inc. | Intraocular lens storage and loading devices and methods of use |
| US9592151B2 (en) | 2013-03-15 | 2017-03-14 | Glaukos Corporation | Systems and methods for delivering an ocular implant to the suprachoroidal space within an eye |
| US9987163B2 (en) | 2013-04-16 | 2018-06-05 | Novartis Ag | Device for dispensing intraocular substances |
| US9649223B2 (en) | 2013-06-13 | 2017-05-16 | Innfocus, Inc. | Inserter for tubular medical implant devices |
| US9226851B2 (en) | 2013-08-24 | 2016-01-05 | Novartis Ag | MEMS check valve chip and methods |
| RU2648229C1 (ru) | 2013-11-14 | 2018-03-22 | Эквисис, Инк. | Устройство для введения интраокулярного шунта |
| US9044301B1 (en) | 2013-11-25 | 2015-06-02 | Innfocus, Inc. | Methods, systems and devices for treating glaucoma |
| EP3148491B1 (en) | 2014-05-29 | 2020-07-01 | Glaukos Corporation | Implants with controlled drug delivery features and manufacturing method for said implants |
| WO2016011056A1 (en) | 2014-07-14 | 2016-01-21 | Ivantis, Inc. | Ocular implant delivery system and method |
| US9999542B2 (en) * | 2014-07-16 | 2018-06-19 | Doheny Eye Institute | Systems, methods, and devices for cannula insertion |
| US10299958B2 (en) | 2015-03-31 | 2019-05-28 | Sight Sciences, Inc. | Ocular delivery systems and methods |
| MA42406A (fr) | 2015-06-03 | 2018-05-16 | Aquesys Inc | Mise en place de shunt intraoculaire ab externo |
| ES2986006T3 (es) | 2015-06-24 | 2024-11-08 | Healionics Corp | Dispositivo poroso inyectable para el tratamiento de la degeneración macular seca y húmeda relacionada con la edad o la retinopatía diabética |
| ES2905214T3 (es) | 2015-06-26 | 2022-04-07 | Innfocus Inc | Dispositivo para glaucoma |
| CN108135470B (zh) | 2015-08-14 | 2021-03-09 | 伊万提斯公司 | 具有压力传感器和输送系统的眼部植入物 |
| US11925578B2 (en) | 2015-09-02 | 2024-03-12 | Glaukos Corporation | Drug delivery implants with bi-directional delivery capacity |
| US11938058B2 (en) | 2015-12-15 | 2024-03-26 | Alcon Inc. | Ocular implant and delivery system |
| AU2016378890B2 (en) * | 2015-12-24 | 2020-04-23 | Istar Medical | Ocular implant systems |
| US10667947B2 (en) | 2016-06-02 | 2020-06-02 | Aquesys, Inc. | Intraocular drug delivery |
| TW201811280A (zh) | 2016-09-01 | 2018-04-01 | 英福卡斯公司 | 用於插入青光眼分流器之工具 |
| WO2018083620A1 (en) * | 2016-11-02 | 2018-05-11 | Liqid Medical Proprietary Limited | A shunt system, shunt and method for treating an ocular disorder |
| WO2018231485A1 (en) | 2017-06-13 | 2018-12-20 | Innfocus, Inc. | Systems, methods, and apparatus for treatment of glaucoma |
| DE102017117657A1 (de) * | 2017-08-03 | 2019-02-07 | Carl Zeiss Meditec Ag | Vorrichtung zur Beeinflussung eines Augeninnendrucks |
| US11116625B2 (en) | 2017-09-28 | 2021-09-14 | Glaukos Corporation | Apparatus and method for controlling placement of intraocular implants |
| CN113893085B (zh) | 2017-10-06 | 2024-05-24 | 格劳科斯公司 | 用于递送多个眼部植入物的系统和方法 |
| USD846738S1 (en) | 2017-10-27 | 2019-04-23 | Glaukos Corporation | Implant delivery apparatus |
| US11246753B2 (en) | 2017-11-08 | 2022-02-15 | Aquesys, Inc. | Manually adjustable intraocular flow regulation |
| CA3089342A1 (en) | 2018-01-23 | 2019-08-01 | Avisi Technologies, LLC | Method and device for treating eye disease |
| EP4371535A3 (en) | 2018-02-22 | 2024-08-14 | Alcon Inc. | Ocular implant |
| US10952898B2 (en) | 2018-03-09 | 2021-03-23 | Aquesys, Inc. | Intraocular shunt inserter |
| US11135089B2 (en) | 2018-03-09 | 2021-10-05 | Aquesys, Inc. | Intraocular shunt inserter |
| US11446179B2 (en) * | 2018-04-03 | 2022-09-20 | Jack Chu | Ocular device and method for glaucoma treatment |
| US11672701B2 (en) | 2018-10-25 | 2023-06-13 | Amo Groningen B.V. | Bleb control glaucoma shunts |
| WO2020176315A1 (en) * | 2019-02-27 | 2020-09-03 | Innfocus, Inc. | Glaucoma device inserter |
| US11504270B1 (en) | 2019-09-27 | 2022-11-22 | Sight Sciences, Inc. | Ocular delivery systems and methods |
| US12011391B2 (en) | 2020-02-27 | 2024-06-18 | Innfocus, Inc. | Ocular implant |
| CN113367885B (zh) * | 2020-03-10 | 2022-07-29 | 成都米戈思医疗技术有限公司 | 一种青光眼引流管及其材料和植入装置 |
| KR20230130622A (ko) | 2021-01-11 | 2023-09-12 | 알콘 인코포레이티드 | 점탄성 전달을 위한 시스템 및 방법 |
| WO2023137602A1 (zh) * | 2022-01-18 | 2023-07-27 | 苏州朗目医疗科技有限公司 | 一种推注器 |
| CN115737925B (zh) * | 2022-08-08 | 2024-01-16 | 诺一迈尔（苏州）医学科技有限公司 | 一种巩膜加固材料及其制备方法和用途 |
| CN121038750A (zh) * | 2023-04-03 | 2025-11-28 | 格劳克尔有限公司 | 用于调节眼内压的装置 |
| EP4628052A1 (en) | 2024-04-02 | 2025-10-08 | Zoran Vatavuk | Intraocular lens capsule kit featuring capsule drainage |
| CN119184958B (zh) * | 2024-10-12 | 2025-04-25 | 首都医科大学附属北京同仁医院 | 房水引流器及房水引流器推注系统 |
Family Cites Families (49)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4254509A (en) * | 1979-04-09 | 1981-03-10 | Tennant Jerald L | Accommodating intraocular implant |
| US4316973A (en) * | 1979-09-10 | 1982-02-23 | The University Of Akron | Novel telechelic polymers and processes for the preparation thereof |
| US4342849A (en) * | 1979-09-10 | 1982-08-03 | The University Of Akron | Novel telechelic polymers and processes for the preparation thereof |
| US4276394A (en) * | 1979-09-10 | 1981-06-30 | The University Of Akron | Novel telechelic polymers, block copolymers and processes for the preparation thereof |
| US4298996A (en) * | 1980-07-23 | 1981-11-10 | Barnet Ronald W | Magnetic retention system for intraocular lens |
| US4897255A (en) * | 1985-01-14 | 1990-01-30 | Neorx Corporation | Metal radionuclide labeled proteins for diagnosis and therapy |
| US5122572A (en) * | 1985-06-20 | 1992-06-16 | Kennedy Joseph P | Living catalysts, complexes and polymers therefrom |
| US4910321A (en) * | 1985-06-20 | 1990-03-20 | University Of Akron | Living catalysts, complexes and polymers therefrom |
| US5066730A (en) * | 1986-08-25 | 1991-11-19 | The University Of Akron | Living polymerization of olefins to end-functionalized polymers |
| US4929683A (en) * | 1986-08-25 | 1990-05-29 | University Of Akron | Living polymerization of olefin to end-functionalized polymers |
| US4842601A (en) * | 1987-05-18 | 1989-06-27 | Smith S Gregory | Accommodating intraocular lens and method of implanting and using same |
| CS271606B1 (en) * | 1988-04-11 | 1990-10-12 | Sulc Jiri | Intraocular optical system |
| US4936825A (en) * | 1988-04-11 | 1990-06-26 | Ungerleider Bruce A | Method for reducing intraocular pressure caused by glaucoma |
| US4994082A (en) * | 1988-09-09 | 1991-02-19 | Ophthalmic Ventures Limited Partnership | Accommodating intraocular lens |
| US4946899A (en) * | 1988-12-16 | 1990-08-07 | The University Of Akron | Thermoplastic elastomers of isobutylene and process of preparation |
| US6197059B1 (en) * | 1990-04-27 | 2001-03-06 | Medevec Licensing, B.V. | Accomodating intraocular lens |
| US5047051A (en) * | 1990-04-27 | 1991-09-10 | Cumming J Stuart | Intraocular lens with haptic anchor plate |
| US5634943A (en) * | 1990-07-12 | 1997-06-03 | University Of Miami | Injectable polyethylene oxide gel implant and method for production |
| US5811447A (en) * | 1993-01-28 | 1998-09-22 | Neorx Corporation | Therapeutic inhibitor of vascular smooth muscle cells |
| US5275623A (en) * | 1991-11-18 | 1994-01-04 | Faezeh Sarfarazi | Elliptical accommodative intraocular lens for small incision surgery |
| US6692525B2 (en) * | 1992-02-28 | 2004-02-17 | Advanced Medical Optics, Inc. | Intraocular lens |
| JPH08117267A (ja) * | 1994-10-28 | 1996-05-14 | Tomey Technol Corp | 房水流出具 |
| US5968058A (en) * | 1996-03-27 | 1999-10-19 | Optonol Ltd. | Device for and method of implanting an intraocular implant |
| US5741331A (en) * | 1996-07-29 | 1998-04-21 | Corvita Corporation | Biostable elastomeric polymers having quaternary carbons |
| AU724849B2 (en) | 1996-08-28 | 2000-10-05 | Facultes Universitaires Notre-Dame De La Paix | New Brucella antigens, recombinant polypeptides, nucleic acids coding for the same and use thereof in diagnostic and prophylactic methods and kits |
| AUPO394496A0 (en) * | 1996-11-29 | 1997-01-02 | Lions Eye Institute | Biological microfistula tube and implantation method and apparatus |
| FR2757064B1 (fr) * | 1996-12-13 | 2000-02-04 | Ioltechnologie Production | Lentille intraoculaire contenant un medicament relargable |
| US6050970A (en) * | 1997-05-08 | 2000-04-18 | Pharmacia & Upjohn Company | Method and apparatus for inserting a glaucoma implant in an anterior and posterior segment of the eye |
| US6001128A (en) * | 1997-05-29 | 1999-12-14 | Alcon Laboratories, Inc. | Materials for use in glaucoma filtration devices |
| US6027531A (en) * | 1997-10-14 | 2000-02-22 | Tassignon; Marie-Joseb. R. | Intraocular lens and method for preventing secondary opacification |
| ATE206314T1 (de) * | 1998-04-15 | 2001-10-15 | Alcon Lab Inc | Beschichtungszusammensetzung für intraocularen linsen |
| RU2234894C2 (ru) * | 1999-04-26 | 2004-08-27 | Джи-Эм-Пи Вижн Солюшнз, Инк. | Расширительное устройство и способ лечения глаукомы |
| US6258121B1 (en) * | 1999-07-02 | 2001-07-10 | Scimed Life Systems, Inc. | Stent coating |
| US6685741B2 (en) * | 1999-07-29 | 2004-02-03 | Bausch & Lomb Incorporated | Intraocular lenses |
| US6331313B1 (en) * | 1999-10-22 | 2001-12-18 | Oculex Pharmaceticals, Inc. | Controlled-release biocompatible ocular drug delivery implant devices and methods |
| US6726676B2 (en) * | 2000-01-05 | 2004-04-27 | Grieshaber & Co. Ag Schaffhausen | Method of and device for improving the flow of aqueous humor within the eye |
| US6391230B1 (en) * | 2000-02-18 | 2002-05-21 | Bausch & Lomb Incorporated | Intraocular lens manufacturing process |
| US6638239B1 (en) * | 2000-04-14 | 2003-10-28 | Glaukos Corporation | Apparatus and method for treating glaucoma |
| AU2001271417B2 (en) * | 2000-08-30 | 2006-10-05 | Johns Hopkins University | Devices for intraocular drug delivery |
| US20020111590A1 (en) * | 2000-09-29 | 2002-08-15 | Davila Luis A. | Medical devices, drug coatings and methods for maintaining the drug coatings thereon |
| US6545097B2 (en) * | 2000-12-12 | 2003-04-08 | Scimed Life Systems, Inc. | Drug delivery compositions and medical devices containing block copolymer |
| JP2003102765A (ja) * | 2001-09-28 | 2003-04-08 | Takashi Okano | 眼圧調節部材および眼圧調節方法 |
| EP1455698A1 (en) * | 2001-11-21 | 2004-09-15 | Iscience Corporation | Ophthalmic microsurgical system |
| JP4009185B2 (ja) * | 2001-11-30 | 2007-11-14 | 株式会社メニコン | コンタクトレンズの製作方法 |
| US6695881B2 (en) * | 2002-04-29 | 2004-02-24 | Alcon, Inc. | Accommodative intraocular lens |
| US8211455B2 (en) * | 2002-06-19 | 2012-07-03 | Boston Scientific Scimed, Inc. | Implantable or insertable medical devices for controlled delivery of a therapeutic agent |
| JP2004208898A (ja) * | 2002-12-27 | 2004-07-29 | Japan Science & Technology Agency | 緑内障治療用房水排出インプラント |
| US20040193095A1 (en) * | 2003-03-29 | 2004-09-30 | Shadduck John H. | Implants for treating ocular hypertension, methods of use and methods of fabrication |
| US20040236343A1 (en) * | 2003-05-23 | 2004-11-25 | Taylor Jon B. | Insertion tool for ocular implant and method for using same |
-
2004
- 2004-12-03 ES ES04813050.4T patent/ES2449496T3/es not_active Expired - Lifetime
- 2004-12-03 AU AU2004296205A patent/AU2004296205B2/en not_active Expired
- 2004-12-03 CA CA2549155A patent/CA2549155C/en not_active Expired - Lifetime
- 2004-12-03 JP JP2006542823A patent/JP5090742B2/ja not_active Expired - Lifetime
- 2004-12-03 US US11/004,539 patent/US7431709B2/en not_active Expired - Lifetime
- 2004-12-03 WO PCT/US2004/040661 patent/WO2005055873A2/en not_active Ceased
- 2004-12-03 EP EP04813050.4A patent/EP1689333B1/en not_active Expired - Lifetime
-
2010
- 2010-02-15 AU AU2010200560A patent/AU2010200560A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| US20050125003A1 (en) | 2005-06-09 |
| EP1689333A2 (en) | 2006-08-16 |
| AU2004296205A1 (en) | 2005-06-23 |
| WO2005055873A3 (en) | 2007-07-26 |
| CA2549155C (en) | 2012-10-16 |
| EP1689333A4 (en) | 2011-03-02 |
| JP2007524477A (ja) | 2007-08-30 |
| AU2010200560A1 (en) | 2010-03-04 |
| CA2549155A1 (en) | 2005-06-23 |
| WO2005055873A2 (en) | 2005-06-23 |
| US7431709B2 (en) | 2008-10-07 |
| EP1689333B1 (en) | 2014-02-12 |
| AU2004296205B2 (en) | 2009-11-12 |
| JP5090742B2 (ja) | 2012-12-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2449496T3 (es) | Dispositivo mejorado de implante para glaucoma | |
| US20220249286A1 (en) | Ocular implant with stiffness qualities, methods of implantation and system | |
| US20190321225A1 (en) | Combined treatment for cataract and glaucoma treatment | |
| US7163543B2 (en) | Combined treatment for cataract and glaucoma treatment | |
| ES2642584T3 (es) | Dispositivo para drenar fluidos y reducir la presión intraocular | |
| ES2762239T3 (es) | Dispositivo de tratamiento del glaucoma | |
| US8672870B2 (en) | Ocular implant with hydrogel expansion capabilities | |
| US20070212397A1 (en) | Pharmaceutical delivery device and method for providing ocular treatment | |
| ES2797776T3 (es) | Un dispositivo quirúrgico oftálmico |